Managed Care Meeting Will Focus on Diabetes Patient Outcomes

  • Mar 2019

On Thursday April 4, The American Journal of Managed Care will host a regional Institute for Value-Based Medicine® meeting on the advances in treatment and management to reduce cost and improve outcomes of patients with diabetes  from 5:30-9:00 p.m. at The Statler Dallas in Texas.

This meeting will feature four presenters: Endocrine Society member Jaime Davidson, MD, FACP, MACE, clinical professor of medicine at Touchstone Diabetes Center in the division of endocrinology, diabetes, and metabolism at the University of Texas (UT) Southwestern Medical Center, will be the chairman and moderator;Ian Neeland, MD, assistant professor in the department of internal medicine at UT Southwestern Medical Center; Jennifer Reed, LCSW, vice president of comprehensive care management at Baylor Scott & White Health; and Kellie Rodriguez, RN, MSN, MBA, CDE, director of the global diabetes program at Parkland Health & Hospital System.

The Institute for Value-Based Medicine® is an informative regional series that focuses on multi-stakeholder perspectives from physicians, payers and practice executives. With a goal to discuss pressing topics, such as the implications of value-based medicine on clinical practice, best practices in team-based diabetes care from leading health systems, and innovative models for population health management, the program features leading clinicians and managed care experts.

Click here for more information.

You may also like

  • Liraglutide Increases Insulin Sensitivity Independent of Weight Loss, Study Shows

    Liraglutide, the glucagon-like peptide-1 receptor (GLP-1R) agonist used to treat type 2 diabetes and obesity, can lead to rapid improvement in insulin sensitivity, according to a study recently published in Diabetes. “We know that GLP-1R agonists promote weight loss, but we were surprised to find that the GLP-1R agonist liraglutide also has rapid effects on…

  • COVID-19 Vaccines and Hyperglycemia in Patients with Type 1 Diabetes

    By Derek Bagley

    While proven to be safe, the COVID-19 vaccines could cause some people with type 1 diabetes to see their blood sugar to temporarily spike. The key for both patient and provider is to remain vigilant with glucose testing and insulin dosing post-jab to maintain glycemic control.  In the summer of 2021, a 24-year-old woman presented…

Find more in